{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:01:48Z","timestamp":1761310908676},"reference-count":9,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2014,4,21]],"date-time":"2014-04-21T00:00:00Z","timestamp":1398038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Congenital Anomalies"],"published-print":{"date-parts":[[2014,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mother\u2010to\u2010child infections cause congenital infection with disease and sequelae. To evaluate a state of maternal blood screening for mother\u2010to\u2010child infections in <jats:styled-content style=\"fixed-case\">J<\/jats:styled-content>apan, we for the first time conducted a nationwide survey on obstetric facilities where regular maternity checkups were carried out. A questionnaire assessment involved an annual number of deliveries, scale of facilities and a state of maternal blood screening for eight pathogens. A high rate (73.7%) of reply to the questionnaire was achieved from 1990 facilities, covering 75.1% of annual number of delivery in 2011. The performance rates of blood screening were more than 99% for rubella virus, <jats:italic><jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>reponema pallidum<\/jats:italic>, human immunodeficiency virus (<jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>), human <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content> cell leukemia virus type 1 (<jats:styled-content style=\"fixed-case\">HTLV<\/jats:styled-content>\u20101), hepatitis <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content> virus, and hepatitis <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content> virus, while the rate was found to be only 4.5% for cytomegalovirus (<jats:styled-content style=\"fixed-case\">CMV<\/jats:styled-content>), and 48.5% for <jats:italic><jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>oxoplasma gondii<\/jats:italic> with large differences in regions. Most of the facilities performed blood tests for rubella virus, <jats:italic><jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>reponema pallidum<\/jats:italic>, <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>, hepatitis <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content> virus and hepatitis <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content> virus once in early pregnancy, while approximately 28% of the facilities performed blood tests for <jats:styled-content style=\"fixed-case\">HTLV<\/jats:styled-content>\u20101 once during the 2nd or 3rd trimester. Most of the facilities used <jats:styled-content style=\"fixed-case\">HA<\/jats:styled-content> tests for <jats:italic><jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>oxoplasma gondii<\/jats:italic>, whereas there was a wide variation in antibody measurement methods for <jats:styled-content style=\"fixed-case\">CMV<\/jats:styled-content>. Generally, the obstetric facilities in <jats:styled-content style=\"fixed-case\">J<\/jats:styled-content>apan have performed maternal blood screening properly according to the current recommendations. The results of this survey involve important information and are helpful for clinical practitioners.<\/jats:p>","DOI":"10.1111\/cga.12044","type":"journal-article","created":{"date-parts":[[2013,12,12]],"date-time":"2013-12-12T03:10:55Z","timestamp":1386817855000},"page":"100-103","source":"Crossref","is-referenced-by-count":9,"title":["Nationwide survey of maternal screening for mother\u2010to\u2010child infections in <scp>J<\/scp>apan"],"prefix":"10.1111","volume":"54","author":[{"given":"Hideto","family":"Yamada","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology Kobe University Graduate School of Medicine  Kobe Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Tairaku","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Kobe University Graduate School of Medicine  Kobe Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Morioka","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Kobe University Graduate School of Medicine  Kobe Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Ebina","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Kobe University Graduate School of Medicine  Kobe Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Sonoyama","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Kobe University Graduate School of Medicine  Kobe Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Tanimura","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Kobe University Graduate School of Medicine  Kobe Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Deguchi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Kobe University Graduate School of Medicine  Kobe Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Nagamata","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Kobe University Graduate School of Medicine  Kobe Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,4,21]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"1273","article-title":"Cytomegalovirus seropositivity in pregnant women in Japan during 1996\u20132009","volume":"46","author":"Azuma H","year":"2010","journal-title":"J Jpn Soc Perin Neon Med"},{"key":"e_1_2_6_3_1","volume-title":"Guideline for obstetrical practice in Japan","author":"Guideline for Obstetrical Practice in Japan","year":"2011"},{"key":"e_1_2_6_4_1","first-page":"22","volume-title":"Maternal and child health statistics of Japan","author":"Kamiya K","year":"2013"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2011-000118"},{"key":"e_1_2_6_6_1","first-page":"20","article-title":"Seroprevalence rates of Toxoplasma gondii in pregnant women of Hokkaido","volume":"51","author":"Nishikawa A","year":"2006","journal-title":"J Hokkaido Obstet Gynecol Soc"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.05486-11"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60072-5"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182897c36"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02092-10"}],"container-title":["Congenital Anomalies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcga.12044","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cga.12044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:52:21Z","timestamp":1696294341000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cga.12044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,21]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.1111\/cga.12044"],"URL":"https:\/\/doi.org\/10.1111\/cga.12044","archive":["Portico"],"relation":{},"ISSN":["0914-3505","1741-4520"],"issn-type":[{"value":"0914-3505","type":"print"},{"value":"1741-4520","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,21]]}}}